These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31220365)

  • 1. The Effect of a Screening and Treatment Program for the Prevention of Fractures in Older Women: A Randomized Pragmatic Trial.
    Merlijn T; Swart KM; van Schoor NM; Heymans MW; van der Zwaard BC; van der Heijden AA; Rutters F; Lips P; van der Horst HE; Niemeijer C; Netelenbos JC; Elders PJ
    J Bone Miner Res; 2019 Nov; 34(11):1993-2000. PubMed ID: 31220365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis.
    Merlijn T; Swart KMA; van der Horst HE; Netelenbos JC; Elders PJM
    Osteoporos Int; 2020 Feb; 31(2):251-257. PubMed ID: 31838551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures-A Post Hoc Analysis of the SCOOP Study.
    McCloskey E; Johansson H; Harvey NC; Shepstone L; Lenaghan E; Fordham R; Harvey I; Howe A; Cooper C; Clarke S; Gittoes N; Heawood A; Holland R; Marshall T; O'Neill TW; Peters TJ; Redmond N; Torgerson D; Kanis JA;
    J Bone Miner Res; 2018 Jun; 33(6):1020-1026. PubMed ID: 29480960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial.
    Shepstone L; Lenaghan E; Cooper C; Clarke S; Fong-Soe-Khioe R; Fordham R; Gittoes N; Harvey I; Harvey N; Heawood A; Holland R; Howe A; Kanis J; Marshall T; O'Neill T; Peters T; Redmond N; Torgerson D; Turner D; McCloskey E;
    Lancet; 2018 Feb; 391(10122):741-747. PubMed ID: 29254858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.
    Rubin KH; Rothmann MJ; Holmberg T; Høiberg M; Möller S; Barkmann R; Glüer CC; Hermann AP; Bech M; Gram J; Brixen K
    Osteoporos Int; 2018 Mar; 29(3):567-578. PubMed ID: 29218381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study.
    Condurache CI; Chiu S; Chotiyarnwong P; Johansson H; Shepstone L; Lenaghan E; Cooper C; Clarke S; Khioe RFS; Fordham R; Gittoes N; Harvey I; Harvey NC; Heawood A; Holland R; Howe A; Kanis JA; Marshall T; O'Neill TW; Peters TJ; Redmond NM; Torgerson D; Turner D; McCloskey E;
    Osteoporos Int; 2020 Mar; 31(3):457-464. PubMed ID: 31960099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Mortality and Subsequent Fracture Risk in Patients With a Major and Hip Fracture After the Introduction of a Fracture Liaison Service: A 3-Year Follow-Up Survey.
    Vranken L; de Bruin IJA; Driessen AHM; Geusens PPM; Eisman JA; Center JR; van der Velde RY; Janzing HMJ; Kaarsemaker S; van den Bergh JP; Wyers CE
    J Bone Miner Res; 2022 Oct; 37(10):2025-2032. PubMed ID: 36087016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture.
    Berry SD; Samelson EJ; Pencina MJ; McLean RR; Cupples LA; Broe KE; Kiel DP
    JAMA; 2013 Sep; 310(12):1256-62. PubMed ID: 24065012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.
    Su Y; Lai FTT; Yip BHK; Leung JCS; Kwok TCY
    Osteoporos Int; 2018 Aug; 29(8):1793-1805. PubMed ID: 29774400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Viswanathan M; Reddy S; Berkman N; Cullen K; Middleton JC; Nicholson WK; Kahwati LC
    JAMA; 2018 Jun; 319(24):2532-2551. PubMed ID: 29946734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study.
    Fu SH; Wang CY; Hung CC; Lee CC; Yang RS; Huang CC; Farn CJ; Lin WH; Chen HM; Hsiao FY; Lin JW; Li CY
    J Intern Med; 2021 Dec; 290(6):1194-1205. PubMed ID: 34237171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for women with increased risk of fragility fractures in a general female population using digital X-ray radiogrammetry (DXR).
    Wilczek ML; Bhatta L; Brumpton BM; Freyschuss B; Brismar TB
    Maturitas; 2021 Feb; 144():60-67. PubMed ID: 33358210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world effectiveness of osteoporosis screening in older Swedish women (SUPERB).
    Zoulakis M; Axelsson KF; Litsne H; Johansson L; Lorentzon M
    Bone; 2024 Oct; 187():117204. PubMed ID: 39019129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway.
    Hoff M; Meyer HE; Skurtveit S; Langhammer A; Søgaard AJ; Syversen U; Dhainaut A; Skovlund E; Abrahamsen B; Schei B
    Osteoporos Int; 2017 Oct; 28(10):2935-2944. PubMed ID: 28668994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study.
    Turner DA; Khioe RFS; Shepstone L; Lenaghan E; Cooper C; Gittoes N; Harvey NC; Holland R; Howe A; McCloskey E; O'Neill TW; Torgerson D; Fordham R;
    J Bone Miner Res; 2018 May; 33(5):845-851. PubMed ID: 29470854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older.
    Elders PJM; Merlijn T; Swart KMA; van Hout W; van der Zwaard BC; Niemeijer C; Heymans MW; van der Heijden AA; Rutters F; van der Horst HE; Lips P; Netelenbos JC; van Schoor NM
    BMC Musculoskelet Disord; 2017 Oct; 18(1):424. PubMed ID: 29078762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation.
    Pedersen AB; Heide-Jørgensen U; Sørensen HT; Prieto-Alhambra D; Ehrenstein V
    JAMA Netw Open; 2019 Apr; 2(4):e192416. PubMed ID: 31002319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive screening for osteoporosis in patients with hip fracture.
    Amar AOS; Hyldstrup L; Nielsen J; Palm H; Jensen JB
    Arch Osteoporos; 2019 Jun; 14(1):63. PubMed ID: 31214797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Added Value of SARC-F to Prescreening Using FRAX for Hip Fracture Prevention in Older Community Adults.
    Su Y; Woo JW; Kwok TCY
    J Am Med Dir Assoc; 2019 Jan; 20(1):83-89. PubMed ID: 30314676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.